hemodynamic recovery after restoration of sinus rhythm after complete atrioventricular block during off pump coronary artery bypass surgery a case report

Original title: “Hemodynamic recovery after restoration of sinus rhythm after complete atrioventricular block during off-pump coronary artery bypass surgery: a case report.”

The results were seen by Wall Street analysts as “direct proof-of-concept” that sac-TMT, a drug Merck views as a “cornerstone,” could be part of a future treatment standard for front-line lung cancer.

Original title: “Merck ADC, in China study, shows potential to replace chemo in lung cancer”

New mid-stage data from Biogen’s Ionis-partnered therapy diranersen served to both validate the tau hypothesis in Alzheimer’s disease and raise questions that could soon be elucidated by anti-tau candidates from Denali Therapeutics, Eisai and Eli Lilly.

Original title: “AAIC 2026: Anti-tau space begins to clarify as Biogen presents detailed data on antisense drug”

Biogen’s new data, presented at the Alzheimer's Association International Conference, supports a tau-focused approach to the intractable neurodegenerative disease; psychedelics are back in the news with more positive data from Compass Pathways and final guidance from the FDA; and the ATTR-CM space got a major shakeup with the late-stage failure of AstraZeneca and Ionis’ antisense therapeutic.

Original title: “Biogen validates anti-tau approach at AAIC, psychedelics full speed ahead, ATTR-CM shakeup”

Eli Lilly’s anti-amyloid Alzheimer’s drug is designed to be stopped after patients drop below a certain amyloid level in the brain. However, at the Alzheimer’s Association International Conference on Wednesday, Lilly revealed it is studying the potential of maintenance therapy for patients who need it.

Original title: “AAIC 2026: Lilly keeps door open for maintenance Kisunla after amyloid clearance”

Medical posters will focus on the assessment and clinical management of two ultra-rare diseases: "A Sub-analysis of Historical Symptoms and Medical Interventions in Subjects with Type 1 Plasminogen Deficiency (PLGD-1) Prior to Plasminogen Replacement Therapy," a study of PLGD-1 early stages, ... Medical posters will focus on the assessment and clinical management of two ultra-rare diseases: "A Sub-analysis of Historical Symptoms and Medical Interventions in Subjects with Type 1 Plasminogen Deficiency (PLGD-1) Prior to Plasminogen Replacement Therapy," a study of PLGD-1 early stages, from symptom onset to diagnosis. "At Kedrion, advancing care for patients with rare diseases begins with generating evidence that may help clinicians make more informed decisions," said Manuela Scarpellini, Global Medical Therapeutic Area Lead for Hematology at Kedrion. "As a multisystem disease that can affect patients from early childhood through adulthood, plasminogen deficiency requires greater awareness among clinicians so patients can receive appropriate care as early as possible." Kedrion's abstract presentations took place today during ISTH 2026 in Paris. ... Kedrion Biopharma collects and fractionates blood plasma to produce and distribute plasma‑derived therapies for rare, ultra‑rare, and debilitating conditions, including coagulation and neurological disorders, immunodeficiencies, and Rh sensitization. FORT LEE, N.J., July 14, 2026 /PRNewswire/ -- Kedrion Biopharma, a biopharmaceutical company that produces and distributes plasma-derived therapies for treating rare and ultra-rare diseases, brought new scientific insights, expert-led discussions, and rare disease evidence generation to the 34th International Society on Thrombosis and Haemostasis (ISTH) Congress in Paris, contributing to ongoing efforts to improve outcomes for patients. "Scientific leadership is an essential part of how we deliver for patients," said Bob Rossilli, Chief Commercial Officer, Kedrion Biopharma. "By investing in clinical research, collaborating with experts, and sharing new evidence at forums like ISTH, we're helping advance the understanding of rare diseases while supporting better care for patients around the world."

Original title: “Kedrion Biopharma Advances Rare Disease Scientific Evidence Generation at ISTH 2026 - BioSpace”

dna methylation signatures distinguish extranodal nk t cell lymphoma and ebv positive nodal t nk cell lymphoma and identify prognostic subgroups

Original title: “DNA methylation signatures distinguish extranodal NK/T-cell lymphoma and EBV-positive nodal T/NK-cell lymphoma and identify prognostic subgroups.”

identification of novel serum proteins that distinguish idiopathic recurrent aphthous stomatitis from behcet s disease

Original title: “Identification of novel serum proteins that distinguish idiopathic recurrent aphthous stomatitis from Behcet's disease.”

age stratified presentation and outcomes following repair of anomalous left coronary artery from the pulmonary artery

Original title: “Age-Stratified Presentation and Outcomes Following Repair of Anomalous Left Coronary Artery From the Pulmonary Artery.”

effects of respiratory muscle training on respiratory function in patients with amyotrophic lateral sclerosis a systematic review and meta analysis

Original title: “Effects of respiratory muscle training on respiratory function in patients with amyotrophic lateral sclerosis: a systematic review and meta-analysis.”

advancing the diagnosis of rare neuromuscular and neurological diseases through the collaborative solve rd research framework

Original title: “Advancing the diagnosis of rare neuromuscular and neurological diseases through the collaborative Solve-RD research framework.”

aminoglycosides is there an effective alternative in severe tularaemia a case series

Original title: “Aminoglycosides: Is there an effective alternative in severe tularaemia? A case series.”

case of cdc73 mutation related primary hyperparathyroidism with ectopic parathyroid hyperplasia

Original title: “A case of CDC73 mutation-related primary hyperparathyroidism with ectopic parathyroid hyperplasia.”

prophylaxis and management of thromboembolism in pnh patients an italian survey

Original title: “Prophylaxis and management of thromboembolism in pnh patients: an italian survey.”

psychological distress symptom burden and quality of life in patients with mycosis fungoides and s zary syndrome

Original title: “Psychological Distress, Symptom Burden and Quality of Life in Patients with Mycosis Fungoides and Sézary Syndrome.”

exercise training in hypertrophic cardiomyopathy a systematic review meta analysis and meta regression

Original title: “Exercise Training in Hypertrophic Cardiomyopathy: A Systematic Review, Meta-analysis, and Meta-regression.”

many faces of perivascular epithelioid cell tumors case series illustrating the spectrum of a rare mesenchymal tumor

Original title: “The many faces of perivascular epithelioid cell tumors: case series illustrating the spectrum of a rare mesenchymal tumor.”

integrated genetic and biochemical approach to patients with bone disorders exhibiting low alkaline phosphatase

Original title: “Integrated Genetic and Biochemical Approach to Patients with Bone Disorders Exhibiting Low Alkaline Phosphatase.”